IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 1 filers reported holding IVERIC BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,010 | -42.0% | 51,101 | -64.1% | 0.09% | -47.0% |
| Q1 2023 | $3,466 | +3.2% | 142,441 | -9.2% | 0.16% | -11.8% |
| Q4 2022 | $3,359 | -99.9% | 156,900 | -12.9% | 0.19% | -4.6% |
| Q3 2022 | $3,233,000 | +104.4% | 180,210 | +9.6% | 0.20% | +63.9% |
| Q2 2022 | $1,582,000 | +99.7% | 164,468 | +249.4% | 0.12% | +128.8% |
| Q1 2022 | $792,000 | +230.0% | 47,078 | +228.2% | 0.05% | +73.3% |
| Q4 2021 | $240,000 | -53.1% | 14,344 | -54.5% | 0.03% | -55.9% |
| Q3 2021 | $512,000 | +279.3% | 31,521 | +46.9% | 0.07% | +51.1% |
| Q2 2021 | $135,000 | -66.2% | 21,457 | -66.8% | 0.04% | -64.8% |
| Q1 2021 | $399,000 | -71.2% | 64,547 | -67.8% | 0.13% | -67.6% |
| Q4 2020 | $1,386,000 | +15.8% | 200,521 | -5.5% | 0.40% | +3.9% |
| Q3 2020 | $1,197,000 | +407.2% | 212,261 | +358.9% | 0.38% | +375.0% |
| Q2 2020 | $236,000 | +84.4% | 46,254 | +24.4% | 0.08% | +48.1% |
| Q1 2020 | $128,000 | – | 37,170 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 2,516,920 | $42,360,000 | 17.00% |
| COMMODORE CAPITAL LP | 2,214,961 | $37,278,000 | 8.33% |
| Ally Bridge Group (NY) LLC | 650,000 | $10,940,000 | 8.11% |
| Vivo Capital, LLC | 6,431,940 | $108,250,000 | 7.45% |
| Samsara BioCapital, LLC | 1,262,551 | $21,249,000 | 5.35% |
| Deep Track Capital, LP | 4,500,000 | $75,735,000 | 4.86% |
| ACUTA CAPITAL PARTNERS, LLC | 539,500 | $9,080,000 | 4.24% |
| Paradigm Biocapital Advisors LP | 910,416 | $15,322,000 | 4.05% |
| Logos Global Management LP | 1,800,000 | $30,294,000 | 3.93% |
| Yiheng Capital Management, L.P. | 5,058,585 | $85,136,000 | 3.89% |